Hemant Surgical Industries Ltd
HSILHemant Surgical Industries Ltd
HSILPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 2.70 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Peers
Compare with peersAchyut Healthcare Ltd
Royal Sense Ltd
Chandra Bhagat Pharma Ltd
Dipna Pharmachem Ltd
Checkpoint Trends Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 39.85 | 51.73 | 50.83 | 56.15 | 56.52 | 60.65 | 105.77 | 111.50 | 109.92 | — | ||||||||||
Raw Materials | 30.29 | 38.78 | 40.59 | 47.60 | 45.58 | 49.72 | 81.49 | 81.97 | 80.16 | — | ||||||||||
Power & Fuel Cost | 0.18 | 0.27 | 0.29 | 0.46 | 0.45 | 0.35 | 0.55 | 0.69 | 0.75 | |||||||||||
Employee Cost | 1.17 | 1.21 | 1.56 | 1.83 | 2.60 | 2.61 | 4.62 | 5.51 | 5.73 | |||||||||||
Selling & Administrative Expenses | 1.60 | 2.20 | 3.62 | 4.52 | 4.90 | 2.78 | 8.56 | 10.59 | 10.06 | |||||||||||
Operating & Other expenses | 4.06 | 6.60 | 2.01 | -1.42 | 0.04 | 1.17 | 2.04 | -0.16 | -1.56 | |||||||||||
EBITDA | 2.55 | 2.67 | 2.76 | 3.16 | 2.95 | 4.02 | 8.51 | 12.90 | 14.78 | — | ||||||||||
Depreciation/Amortization | 0.18 | 0.26 | 0.42 | 0.53 | 0.49 | 0.89 | 0.75 | 0.85 | 1.03 | — | ||||||||||
PBIT | 2.37 | 2.41 | 2.34 | 2.63 | 2.46 | 3.13 | 7.76 | 12.05 | 13.75 | — | ||||||||||
Interest & Other Items | 1.72 | 1.56 | 1.31 | 1.40 | 1.60 | 1.64 | 1.64 | 1.99 | 0.97 | — | ||||||||||
PBT | 0.65 | 0.85 | 1.03 | 1.23 | 0.86 | 1.49 | 6.12 | 10.06 | 12.78 | — | ||||||||||
Taxes & Other Items | 0.03 | 0.05 | 0.10 | 0.10 | 0.35 | 0.13 | 1.50 | 2.42 | 2.98 | — | ||||||||||
Net Income | 0.62 | 0.80 | 0.93 | 1.13 | 0.51 | 1.36 | 4.62 | 7.64 | 9.80 | — | ||||||||||
EPS | 4.13 | 4.85 | 4.89 | 5.65 | 2.55 | 6.80 | 23.10 | 15.79 | 10.82 | — | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHealth Care Distributors
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Hemant Surgical Industries Ltd | 15.11 | 2.70 | — |
Achyut Healthcare Ltd | 193.55 | 3.65 | — |
Royal Sense Ltd | 65.37 | 5.70 | — |
Chandra Bhagat Pharma Ltd | 35.97 | 1.87 | — |
Price Comparison
Compare HSIL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Jun 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
HSIL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hemant Surgical Industries will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Hemant Surgical Industries announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 14.38%, vs industry avg of 16.25%
Decreasing Market Share
Over the last 5 years, market share decreased from 22.42% to 20.01%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 54.04%, vs industry avg of 29.96%